Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010)
Compugen (CGEN) reported Depreciation & Amortization (CF) of $50000.0 for Q4 2010, up 316.67% on a YoY basis from $12000.0 in Q4 2009, and down 1.96% sequentially from $51000.0 in Q3 2010.
Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010) Analysis & Trends
Compugen (CGEN) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $50000.0 in Q4 2010.
- For the quarter ending Q4 2010, Depreciation & Amortization (CF) rose 316.67% year-over-year to $50000.0; the trailing twelve-month figure through Sep 2011 stood at $50000.0 (down 20.63% YoY), and the FY2025 full-year result was $475000.0, down 2.26% from the prior year.
- Depreciation & Amortization (CF) fell to $50000.0 in Q4 2010, from $51000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $51000.0 in Q3 2010 to a low of $12000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 50,000.00 |
| Dec 31, 2010 | 50,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Sep 30, 2009 | 48,000.00 |
| Sep 30, 2009 | 48,000.00 |